Početna › Rak prostate › Maryland
Kliničke studije za Rak prostate u državi Maryland
65 studija za Rak prostate traži sudionike na lokacijama u državi Maryland.
Gradovi u državi Maryland
Službeni tekst studije (engleski)
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaOpažajna studija
Od 18 do 120 godina · Muškarci · Ažurirano 2. lis 2026. · NCT01834001IL-15 Superagonist With or Without Vaccine in Biochemically Recurrent Prostate Cancer After Previous Stereotactic Body Radiation Therapy
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaFaza 2
Od 18 do 120 godina · Muškarci · Ažurirano 2. lis 2026. · NCT07686380Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
- Maryland Proton Treatment Center, Baltimore
- University of Maryland/Greenebaum Cancer Center, Baltimore
- UM Upper Chesapeake Medical Center, Bel Air
- i još 3
U tijeku regrutacijaFaza 3
Od 18 godina i više · Muškarci · Ažurirano 2. lis 2026. · NCT07200830Collection of Blood From Patients With Prostate Cancer
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Muškarci · Ažurirano 2. lis 2026. · NCT00923221Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mercy Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- i još 10
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 40 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT05334069Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaOpažajna studija
Od 3 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT01441089A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Johns Hopkins University, Baltimore
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06172478Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- National Institutes of Health Clinical Center, Bethesda
- FMH James M Stockman Cancer Institute, Frederick
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT03866382Collection of Blood From Patients With Cancer
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT00034216Precision-Based Genomics in Prostate Cancer
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaOpažajna studija
Od 18 do 120 godina · Muškarci · Ažurirano 28. ruj 2026. · NCT04706663Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix
- Chesapeake Urology Associates, Hanover
- Chesapeake Urology Associates, Towson
U tijeku regrutacijaOpažajna studija
Od 40 do 75 godina · Muškarci · Ažurirano 28. ruj 2026. · NCT07543757Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
- University of Maryland, Greenebaum Comprehensive Cancer Center, Baltimore
U tijeku regrutacijaFaza 1
Od 18 godina i više · Muškarci · Ažurirano 25. ruj 2026. · NCT06801236A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Baltimore Veterans Affairs Medical Center ( Site 0069), Baltimore
- Greenebaum Comprehensive Cancer Center ( Site 0049), Baltimore
- Chesapeake Urology ( Site 0009), Towson
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06136650Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Muškarci · Ažurirano 22. ruj 2026. · NCT05588128Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Muškarci · Ažurirano 22. ruj 2026. · NCT02594202A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- University of Maryland Greenebaum Cancer Center, Baltimore
- Johns Hopkins Hospital Sidney Kimmell Comprehensive Cancer Center, Baltimore
U tijeku regrutacijaFaza 3
Od 18 godina i više · Muškarci · Ažurirano 22. ruj 2026. · NCT07213674A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Research Site, Towson
U tijeku regrutacijaFaza 3
Od 18 godina i više · Muškarci · Ažurirano 18. ruj 2026. · NCT06952803A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation Therapy
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaFaza 2
Od 18 godina i više · Muškarci · Ažurirano 18. ruj 2026. · NCT05361798Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaFaza 2
Od 18 do 120 godina · Muškarci · Ažurirano 17. ruj 2026. · NCT05616650A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- Greenebaum Comprehensive Cancer Center ( Site 0021), Baltimore
U tijeku regrutacijaFaza 3
Od 18 godina i više · Muškarci · Ažurirano 17. ruj 2026. · NCT06925737PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Muškarci · Ažurirano 15. ruj 2026. · NCT04995198A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
- Chesapeake Urology Research Associates, Towson
U tijeku regrutacijaFaza 2
Od 18 godina i više · Muškarci · Ažurirano 15. ruj 2026. · NCT07332000Sacral Neuromodulation for Male Overactive Bladder (MOAB)
- Anne Arundel Urology, Annapolis
U tijeku regrutacija
Od 18 godina i više · Muškarci · Ažurirano 14. ruj 2026. · NCT06511141Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Maryland Proton Treatment Center, Baltimore
- University of Maryland/Greenebaum Cancer Center, Baltimore
- Veterans Administration Medical Center-Baltimore, Baltimore
- i još 7
U tijeku regrutacijaFaza 3
Od 18 godina i više · Muškarci · Ažurirano 10. ruj 2026. · NCT05946213Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Muškarci · Ažurirano 8. ruj 2026. · NCT03354416Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaFaza 2
Od 18 do 120 godina · Muškarci · Ažurirano 3. ruj 2026. · NCT06096870Patient Navigation Program to Improve Clinical Trial Enrollment in Cancer Patients
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 3. ruj 2026. · NCT06138067Men at High Genetic Risk for Prostate Cancer
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaOpažajna studija
Od 30 do 75 godina · Muškarci · Ažurirano 3. ruj 2026. · NCT03805919A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaFaza 1/2
Od 18 do 110 godina · Muškarci · Ažurirano 3. ruj 2026. · NCT04633252The Vanguard Study: Testing a New Way to Screen for Cancer
- Walter Reed National Military Medical Center, Bethesda
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 45 do 75 godina · Oba spola · Ažurirano 2. ruj 2026. · NCT06995898Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacija
Od 18 godina i više · Muškarci · Ažurirano 27. kol 2026. · NCT04692675Transrectal Ultrasound Robot-Assisted Prostate Biopsy
- Johns Hopkins Hospital, Baltimore
U tijeku regrutacija
Od 45 do 75 godina · Muškarci · Ažurirano 26. kol 2026. · NCT02871726Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
- University of Maryland Greenebaum Cancer Center, Baltimore
U tijeku regrutacijaFaza 2
Od 18 godina i više · Muškarci · Ažurirano 24. kol 2026. · NCT07745361A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
- Johns Hopkins Hospital, Baltimore
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Muškarci · Ažurirano 20. kol 2026. · NCT06785636Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
- Suburban Hospital, Bethesda
U tijeku regrutacijaFaza 3
Od 18 godina i više · Muškarci · Ažurirano 19. kol 2026. · NCT04423211FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Johns Hopkins University, The Sidney Kimmel Comprehensive Cancer Center, Baltimore
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 17. kol 2026. · NCT05919264Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
U tijeku regrutacijaFaza 1
Od 18 do 100 godina · Muškarci · Ažurirano 13. kol 2026. · NCT05519449Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer
- Johns Hopkins University, Baltimore
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Muškarci · Ažurirano 12. kol 2026. · NCT04489719Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer
- National Institutes of Health Clinical Center, Bethesda
U tijeku regrutacijaFaza 2
Od 18 do 120 godina · Muškarci · Ažurirano 24. srp 2026. · NCT06161506Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
- Christiana Care - Union Hospital, Elkton
U tijeku regrutacijaFaza 3
Od 18 godina i više · Muškarci · Ažurirano 14. srp 2026. · NCT06592924Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.